Thirumalai Chemicals Limited

NSE:TIRUMALCHM.NS

332.4 (INR) • At close September 6, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

20232022202120202019201820172016201520142013201220112010200920082007
Revenue 20,831.321,322.419,969.810,849.110,824.212,575.413,105.910,327.5789,441.72110,722.58612,762.38313,714.99510,515.8227,685.2886,256.7934,702.2195,879.79
Cost of Revenue 18,070.415,311.712,319.26,6928,007.58,522.68,138.56,957.0326,634.2038,505.34310,247.04910,564.8458,335.056,088.524,811.4534,074.7744,300.879
Gross Profit 2,760.96,010.77,650.64,157.12,816.74,052.84,967.43,370.5462,807.5182,217.2432,515.3343,150.152,180.7721,596.7681,445.341627.4441,578.912
Gross Profit Ratio 0.1330.2820.3830.3830.260.3220.3790.3260.2970.2070.1970.230.2070.2080.2310.1330.269
Reseach & Development Expenses 24.725.326.42932.533.630.527.10618.31212.40711.60717.38100000
General & Administrative Expenses 171.9194.6112.39578.683.382.561.11759.724025.72953.15500000
Selling & Marketing Expenses 1,033.8994.81,187.1566.3508.8518.5590.3461.76728.8740432.949622.800000
SG&A 2,882.71,189.41,299.4661.3587.4601.8672.8522.88588.598365.828892.171,056.55300000
Other Expenses 193.4301.511.210.617.212.210.23.9684.1084.2334.0294.1883.9443.0232.0151.9381.988
Operating Expenses 2,882.74,705.63,777.12,441.62,419.32,339.32,308.42,111.0272,000.4641,984.7511,918.6862,014.7171,662.1361,215.982874.3761,184.88987.638
Operating Income -121.81,312.73,876.51,719.3395.11,713.52,6591,259.52548.356-68.029148.721644.63520.282248.276380.258-698.74467.823
Operating Income Ratio -0.0060.0620.1940.1580.0370.1360.2030.1220.058-0.0060.0120.0470.0020.0320.061-0.1490.08
Total Other Income Expenses Net -223.7-18.6-122.8-148-13.5-24.9-129-167.447-258.697-300.521-447.927-490.798-498.354-132.51-190.707-141.304-123.45
Income Before Tax -345.51,294.13,753.71,571.3381.61,688.62,5301,092.073548.356-68.029148.721644.63520.282248.276380.258-698.74467.823
Income Before Tax Ratio -0.0170.0610.1880.1450.0350.1340.1930.1060.058-0.0060.0120.0470.0020.0320.061-0.1490.08
Income Tax Expense 42.4395.8941.4394.4149.9552.9825.6386.625226.83669.21830.052181.83911.08178.092121.368-239.298201.454
Net Income -387.9898.32,812.31,176.9231.71,135.71,704.4705.448321.52-137.247118.668438.0919.182179.446258.615-460.009266.706
Net Income Ratio -0.0190.0420.1410.1080.0210.090.130.0680.034-0.0130.0090.0320.0010.0230.041-0.0980.045
EPS -3.798.7727.4711.492.2611.0916.656.93.14-1.341.164.280.0891.752.53-4.492.61
EPS Diluted -3.798.7727.4711.492.2611.0916.656.93.14-1.341.164.280.0891.752.53-4.492.61
EBITDA 510.22,163.44,489.32,234.8923.82,074.92,894.21,558.089888.791399.762826.5921,364.029744.675534.579694.538-435.169703.763
EBITDA Ratio 0.0240.1010.2250.2060.0850.1650.2210.1510.0940.0370.0650.0990.0710.070.111-0.0930.12